
|Articles|July 1, 2003
ISTA begins phase III study of bromfenac
ISTA Pharmaceuticals Inc. has filed an investigational new drug application with the FDA to begin a phase III study of bromfenac.
Advertisement
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
Offline smartphone AI accurately detects DR, glaucoma, and AMD in real-world study
2
Thyroid eye disease specialists react to the FDA approval of veligrotug-vvze
3
Dry Eye Awareness Month: building a strong optometry-ophthalmology co-management model
4
Detecting peripheral retinal lesions in children with myopia
5
























